News & Notices

Medtech contract in Norway



Data Respons has signed a frame agreement with an annual value of NOK 40 million with a Norwegian supplier of medical equipment.


The contract comprise delivery of R&D Services and smart solutions embedded in the customers advanced systems. Deliveries will start in 2019.

- Companies across all industries focus on innovation and development and are leveraging intelligent sensors, advanced connectivity solutions (e.g. IoT) and more data driven processes. This requires specialist competence that are at the core of Data Respons business and competence profile.

Implementation of new technology and new smart solutions will be a prerequisite to enable a more efficient utilisation of resources – everything from asset utilisation, energy optimisation and recycling to knowledge- and competence sharing. Data Respons will play an important role going forwards assisting companies across all industries to leverage technology opportunities. We have a target of completing at least fifty technology development projects annually so that we, together with our customers, can contribute to a more sustainable future, says Kenneth Ragnvaldsen, CEO of Data Respons ASA.


For further information:
Kenneth Ragnvaldsen, CEO, Data Respons ASA, tel. +47 913 90 918.

Rune Wahl, CFO, Data Respons ASA, tel. + 47 950 36 046

About Data Respons
Data Respons is a full-service, independent technology company and a leading player in the IoT, Industrial digitalisation and the embedded solutions market. We provide R&D services and smarter solutions to OEM companies, system integrators and vertical product suppliers in a range of market segments such as Transport & Automotive, Industrial Automation, Telecom & Media, Space, Defence & Security, Medtech, Energy & Maritime, and Finance & Public Sector.

Data Respons ASA is listed on the Oslo Stock Exchange (Ticker: DAT), and is part of the information technology index. The company has offices in Norway, Sweden, Denmark, Germany and Taiwan. www.datarespons.com

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.